This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Judith Newmark, PhD
Associate Director of Pharmacology and Toxicology at Editas Medicine
Speaker

Profile

Judy is currently Associate Director of Pharmacology and Toxicology at Editas Medicine and has spent the past few years focused on advancing the in vivo pipeline. Prior to Editas Judy held various positions in Translational Science at AGTC where she worked on CNS, ocular, and otology related gene therapy programs. She also served as Program Manager and Head of Pharmacology and Toxicology at Toxikon Corporation. Judy received a BS in Biology, and a MS and PhD in Biology, Cell, and Molecular Biology from Northeastern University.

Agenda Sessions

  • LNP Delivery of AsCas12a Enables Liver Editing and Disease-Associated Protein/Biomarker Reduction for Multiple Targets in Mouse and Non-human Primate Preclinical Models

    3:00pm